Aim for a protein source at every meal and snack to support muscle repair and satiety
We're taking the already proven benefits of GLP-1 receptor agonists and looking at a new molecule that integrates GIP action to see what additional benefits are possible." Two statistical approaches were used to evaluate the efficacy of four doses of GIP/GLP-1 RA (1 mg, 5 mg, 10 mg, 15 mg) compared to placebo and dulaglutide 1.5 mg in people with type 2 diabetes
It has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) , and it is not available on NHS prescription
doi: 10.3390/molecules29061377 73 DanciuCAvramPavelIGhiulaiRDeheleanCErsiliaAet al
Renal signals from cardiovascular outcomes trials disclosed less albuminuria and slower estimated glomerular filtration rate (eGFR) decline with GLP1RA therapy, often additive to sodiumglucose cotransporter-2 inhibition
For example, empagliflozin reduced the expression of nuclear deoxyribonucleic acid binding for nuclear factor kappa B (NF-B), activator protein 1, Toll-like receptor-4 and attenuated collagen IV expression as well as interleukin-6 secretion [21]
